It has been well established that muscle contraction is driven by structural rearrangements within myosin during its ATPase cycle and interaction with actin. The crystal structures of myosin (Fig. 1) solved in different nucleotide states have provided a framework for examining the structural basis of the ATPase cycle of myosin (1-6). In addition, solution techniques that include monitoring the intrinsic fluorescence of myosin have proven extremely valuable for examining the enzymatic and kinetic properties of the molecule (7-13). The following kinetic scheme of the myosin MgATPase cycle was developed based on observed changes in intrinsic fluorescence corresponding to structural changes within myosin, where M represents myosin and an asterisk represents enhanced protein fluorescence (14).
It has been well established that muscle contraction is driven by structural rearrangements within myosin during its ATPase cycle and interaction with actin. The crystal structures of myosin (Fig. 1 ) solved in different nucleotide states have provided a framework for examining the structural basis of the ATPase cycle of myosin (1) (2) (3) (4) (5) (6) . In addition, solution techniques that include monitoring the intrinsic fluorescence of myosin have proven extremely valuable for examining the enzymatic and kinetic properties of the molecule (7) (8) (9) (10) (11) (12) (13) . The following kinetic scheme of the myosin MgATPase cycle was developed based on observed changes in intrinsic fluorescence corresponding to structural changes within myosin, where M represents myosin and an asterisk represents enhanced protein fluorescence (14) .
M ϩ ATP7M⅐ATP7M*⅐ATP7M**⅐ADP⅐P i 7M*⅐ADP⅐P i 7M*⅐ADP ϩ P i 7M⅐ADP7M ϩ ADP REACTION 1 In this reaction myosin first forms a collision complex with ATP followed by an isomerization to the M*⅐ATP complex, which results in the first level of fluorescence enhancement (*). During the rapid reversible process of ATP hydrolysis, a structural change induces an additional fluorescence enhancement (**). Then, following hydrolysis of ATP the fluorescence decreases back to the first level of enhancement (*), which is thought to correspond to the rate-limiting structural change resulting in phosphate release. The phosphate release step then shifts myosin from a weak to strong binding conformation and is the step believed to be associated with force generation during muscle contraction. The release of ADP is a much faster two-step process in which the second step results in a decrease in fluorescence to basal levels. Thus, examining the conformational changes that result in alterations in intrinsic tryptophan fluorescence may lead to important insights about the structural properties of the myosin MgATPase cycle.
Dynamic structural information about domain motions within myosin during its MgATPase cycle has been pursued extensively (reviewed in Ref. 15) . Indeed, several studies have demonstrated key rearrangements in the light chain-binding region (residues 781-820 highlighted in pink in Fig. 1 ), also referred to as the lever arm, providing a structural mechanism for force generation (reviewed in Ref. 16 ). Electron paramagnetic resonance studies, utilizing a probe on the regulatory light chain have shown a 30°rotation of this region (17) , suggesting that the lever arm region rotates relative to the catalytic domain during muscle contraction. In addition, fluorescence studies utilizing a fluorescent probe at the regulatory light chain demonstrated rotation of the lever arm in contracting muscle fibers (15) . Cryo-electron microscopy studies have revealed that smooth muscle myosin decorated on actin filaments undergoes a large structural change (30 -35 Å) of the lever arm upon ADP release (18) . Furthermore, nucleotide analogs, which trap myosin in specific nucleotide states, have been useful in elucidating the structural properties of the normally short-lived stages of the MgATPase cycle. Structural studies suggest that MgADP-BeF X 1 corresponds to the M⅐ATP state, and MgADP-AlF 4 Ϫ corresponds to the transition state of ATP hydrolysis (19) , whereas MgATP present at saturating levels at 20°C represents primarily the M⅐ADP⅐P i state (20) . Fluorescence resonance energy transfer (FRET) experiments have shown that the lever arm is further away from the catalytic domain in the MgATP state simulated by MgADP-BeF X , moves closer in the MgADP⅐P i state simulated by MgADP-AlF 4 Ϫ or MgADP-Vi, and moves further away again in the MgADP and rigor states (21, 22) . Although many studies have demonstrated rotation of the lever arm relative to the catalytic domain during the contractile cycle, the structural details of how conformational changes in the catalytic domain are communicated to the lever arm are currently unclear.
The converter region (residues 709 -780, highlighted in blue in Fig. 1 ), a flexible region connecting the lever arm to the motor domain, may be responsible for allowing the lever arm to rotate relative to the catalytic domain. Structural studies have demonstrated large differences in the converter region when comparing the crystal structures of myosin in different nucleotide states (5, 6, 23) . Furthermore, the rigid relay loop (residues 512-518, highlighted in red in Fig. 1 ), which provides a link between the active site and the converter domain as well as actin-binding regions, contains a conserved tryptophan residue (Trp-512 in smooth muscle myosin) that may be sensitive to nucleotide binding and ATP hydrolysis (24 -26) . Thus, examination of conformational changes in Trp-512 of myosin during different stages of the contractile cycle may lead to important insights into the coupling pathways that propagate through the rigid relay loop to the actin-binding and converter/ lever arm regions of myosin. Also, it is still unclear whether other tryptophan residues that are conserved among skeletal muscle, smooth muscle, and Dictyostelium discoideum (Dicty) myosin II (Trp-441 and Trp-597 in smooth muscle myosin) play a role in the intrinsic fluorescence changes that have been demonstrated in all three myosin isoforms (7, 11, 12) .
In the current study, intrinsic tryptophan fluorescence was used to examine changes in the environment of three conserved tryptophans (441, 512, and 597) during the MgATPase cycle of smooth muscle myosin. Three different fragments of smooth muscle myosin, containing the motor domain with the essential light chain (MDE), were engineered to contain a single tryptophan located at each of these positions; 441, 512, or 597. The tryptophan fluorescence from W441-MDE, W512-MDE, and W597-MDE was examined in the presence and absence of nucleotides as well as nucleotide analogs to investigate the contribution of each of these tryptophans to the changes in intrinsic protein fluorescence observed in different stages of the MgATPase cycle. In addition, we examined the movements that occur in the rigid relay loop by monitoring the amount of FRET between Trp-512 and mant-labeled nucleotides and nucleotide analogs. We have identified structural changes that occur in the rigid relay loop upon nucleotide binding and ATP hydrolysis, providing new insights into the structural pathways that couple the active site to the actin-binding and converter/lever arm regions of myosin.
EXPERIMENTAL PROCEDURES
Chemicals-mant-labeled ATP and ADP were purchased from Molecular Probes Inc. (Eugene, OR). KCl, NaCl, ethylene glycol bis(-aminoethyl ether), BeCl 2 , AlCl 3 , NaF, ATP, and ADP were purchased from Sigma. All other reagents were the highest quality available.
Solutions-A stock solution of BeCl 2 (Be, atomic absorption standard solution, in 1% HCl) was adjusted to pH 5.0 by addition of 1 N NaOH. Stock solutions of 1 M NaF were freshly prepared each day. Our standard buffer was MOPS buffer at pH 7.4 and 4°C (20 mM MOPS, 20 mM KCl, 1 mM EGTA, and 1 mM NaN 3 ), and 1 mM dithiothreitol was added when necessary. Imidazole buffer at pH 7.4 and 4°C (10 mM imidazoleHCl, 90 mM NaCl, 1 mM NaN 3 , and 1 mM dithiothreitol) was used during protein purification steps only (described below).
cDNA Construction-We performed site-directed mutagenesis on a clone of smooth muscle myosin heavy chain containing the motor domain and essential light chain binding regions (residues 1-819, kindly provided by Kathleen M. Trybus, University of Vermont) to produce three mutants, each containing a single tryptophan residue. We constructed these mutants containing a single conserved tryptophan residue, Trp-441, Trp-512, or Trp-597, by mutating six of the seven endogenous MDE tryptophans to phenylalanine or methionine in the case of Trp-546 (highlighted as space-filling models in Fig. 1 ). We also constructed as a mutant containing no tryptophans (Null-MDE) and a molecule containing all seven native tryptophans (WT-MDE) described previously (27) . The FLAG epitope sequence (DYKDDDK) was attached at the C terminus of all MDE constructs for purification purposes (28) .
Protein Expression and Purification-The baculovirus system was used to express all MDE constructs by co-infecting Sf9 insect cells with recombinant baculoviruses encoding the desired myosin heavy chain and essential light chain sequences. Following incubation with baculovirus for three days, the Sf9 cells were lysed, fractionated between 40 and 70% saturated ammonium sulfate, and dialyzed overnight in imidazole buffer at 4°C. The dialyzate was bound to an anti-FLAG antibody column, eluted with the homologous peptide, and dialyzed overnight into MOPS buffer with 1 mM dithiothreitol present. The degree of purity of the MDE was assessed by SDS/polyacrylamide gel electrophoresis (29) using Coomassie-stained gels. Purified MDE concentra-FIG. 1. Crystal structure of the smooth muscle myosin MDE construct with the myosin heavy chain (residues 1-819) colored yellow and the essential light chain colored cyan (5). Also, the putative actin-binding region (purple), converter region (blue), switch II region (green), and rigid relay loop (red) are highlighted. Six of the seven endogenous tryptophans, highlighted as space-filling models, were substituted with phenylalanine, or methionine in the case of Trp-546, leaving a single endogenous tryptophan at residue 441, 512, or 597.
tions were determined by the method of Bradford (30) using the Bio-Rad microplate assay and WT-MDE as a standard. All experiments were performed on two or three different MDE preparations.
Actin was purified from chicken pectoralis muscle using an acetone powder method described previously (31) . The concentration of purified actin was determined spectophotometrically using an extinction coefficient of 0.62 (mg/ml) Enzymatic Assays-Actin-activated ATPase assays were performed at 37°C in low ionic strength MOPS buffer using the method of White (33) . Purified MDE was assayed at a concentration of 0.1 mg/ml in the presence of 0, 10, 30, 50, 70, and 90 M actin, and inorganic phosphate production was measured colormetrically every 10 min for a 70-min period. The average ATPase rates (nmol P i ⅐(nmol MDE)
) of two separate preparations of W441-, W512-, W597-, and WT-MDE were plotted as a function of actin concentration and fit with a nonlinear least squares method using GraphPad Prism software (San Diego, CA). Values of V max and K m were determined using Michaelis-Menton kinetics.
Fluorescence Measurements-A Quantamaster fluorimeter (Photon Technology International, South Brunswick, NJ) equipped with a 75-W Xenon arc lamp as an excitation source, excitation/emission monochrometers, and a WG-320 cut-off emission filter was used to measure steady state fluorescence from tryptophan and mant-labeled nucleotides. Tryptophan fluorescence emission spectra were measured by exciting the sample at 295 nm and collecting the emitted fluorescence at 305-400 nm. mant-labeled nucleotides were excited at 360 nm, and the emission spectrum was measured at 380 -500 nm. The excitation spectra of mant-labeled nucleotides were collected at 250 -400 nm with an emission wavelength of 440 nm. Slit widths were set at a resolution of 2 nm. All fluorescence spectra were corrected for variations in the wavelength sensitivity of the detector system and the presence of Raman scatter and background fluorescence in the appropriate buffer solution. Quantum yields (⌽) for tryptophan were calculated by a comparative method (34) using L-tryptophan as a standard (⌽ ϭ 0.14) (35) .
The fluorescence emission spectrum of each of the three mutants was measured in the presence of 2 mM MgADP or MgATP, as well as in the absence of nucleotide. In addition, the fluorescence spectrum of W512-MDE was measured complexed with the nucleotide analogs, MgADPAlF 4 Ϫ and MgADP-BeF X . The binding of mantATP or mantADP to W512-MDE was examined by titrating increasing concentrations of mantADP or mantATP with 0.6 M W512-MDE and monitoring the 2-fold increase in fluorescence of mant at 440 nm, which occurs upon binding to myosin (12) .
Acrylamide quenching was used to determine the degree of exposure to solvent of Trp-512 in the presence of nucleotide and nucleotide analogs. The decrease in fluorescence intensity at the max was measured as a function of increasing acrylamide concentrations ([Q]). The fluorescence in the absence of quencher (F 0 ) divided by the fluorescence in the presence of quencher (F) was used to quantify the relative change in fluorescence from acrylamide quenching (F 0 /F). F 0 /F was plotted as a function of [Q] and fit to the Stern-Volmer relationship, taking into account both static (V) the and dynamic quenching (K SV ) constants: (36) . The static quenching value, which determines the amount of upward curvature of the Stern-Volmer plot, was determined by manually varying V and found to be similar (V ϭ 3.0
) in all cases. Thus, the dynamic quenching constant was determined by fitting the Stern-Volmer plots by a nonlinear least squares method using GraphPad Prism software (San Diego, CA), whereas V was held constant at 3.0 M Ϫ1 . Fluorescence Energy Transfer Measurements-FRET was used to measure the distance between the donor fluorophores, Trp-512, and acceptor fluorophores, mant-labeled nucleotides, using the Förster energy transfer theory (37) . We measured the efficiency (E) of energy transfer by examining the increase in the acceptor excitation intensity upon donor excitation using the following equation.
where F DA285 and F DA360 are the intensities from the excitation spectrum of the acceptor in the presence of the donor, corrected by subtracting the fluorescence from the unbound mant nucleotides, and ⑀ A285 , 
where R 0 is the Förster critical distance at which energy transfer is equal to 50%. The distance R 0 is calculated from Equation 3.
where n is the refractive index of the buffer (Ϸ1. (40) .
where F D () is the normalized total integrated intensity of the unquenched donor group and ⑀ A is the extinction coefficient of the acceptor in M Ϫ1 ⅐cm
Ϫ1
. J was numerically integrated at 1-nm intervals and determined to be 5.18 ϫ 10
3 in all nucleotide states studied, where is the wavelength in centimeters. Because the presence of various nucleotides changed only the intensity and not the shape of the fluorescence emission spectra from W512-MDE, the calculated value of J was relatively insensitive to the nucleotide present at the active site of W512-MDE.
RESULTS
Functional Assays-Functional assays were performed to examine the impact of the conservative mutations made to generate the smooth muscle myosin single tryptophan-containing mutants, W441-, W512, and W597-MDE. All MDE constructs were expressed and purified to similar levels (Ͼ90%) and yields (1-2 mg/1 ϫ 10 9 Sf9 cells). All three mutants displayed V max values that were reduced 4 -5-fold and K m values 2-4-fold lower than WT-MDE (Table I) . Previously, similar MDE mutants were shown to decorate actin with the classic arrowhead appearance as demonstrated by electron microscopy (27) , and thus W441-, W512-, and W597-MDE are likely to bind actin similarly. Most importantly, despite alterations in the ATPase rates, all three mutants display enhanced MgATPase rates in the presence of actin.
Tryptophan Fluorescence Enhancement during the Mg, ATPase Cycle-We examined the fluorescence properties of W441-, W512-, and W597-MDE in the presence of nucleotides and nucleotide analogs to determine how the structural properties of these conserved tryptophans were altered throughout the MgATPase cycle. The fluorescence spectra and emission peak maxima of W441-and W597-MDE (334 and 332 nm, respectively) were unchanged in the presence of either MgATP or MgADP (data not shown). In contrast, the fluorescence properties of W512-MDE demonstrated a 31.0 Ϯ 1.1% increase in (Fig. 2B and Table II) . Interestingly, the fluorescence spectrum of WT-MDE demonstrated an increase in its peak fluorescence intensity of 8.9 Ϯ 2.1% in the presence of MgADP-BeF X , 13.2 Ϯ 1.2% in the presence of MgADP-AlF 4 Ϫ , 18.4 Ϯ 0.0% in the presence of MgATP, and 12.1 Ϯ 0.0% in the presence of MgADP compared with the absence of nucleotide ( Fig. 2A and Table II) . Although the fluorescence enhancement of W512-MDE was 2-3-fold greater than WT-MDE, the level of enhancement followed a similar pattern: greatest in the presence of MgATP, slightly lower in the presence of MgADP-AlF 4 Ϫ , MgADP-BeF X , and MgADP, and lowest in the nucleotide-free state. Thus, Trp-512 appears to be the sole tryptophan of those conserved between skeletal muscle, smooth muscle, and Dicty myosin II that is sensitive to nucleotide binding and hydrolysis, and its enhancement profile was similar to previous studies on smooth muscle myosin (8, 12) .
Acrylamide Quenching of W512-MDE-To examine the solvent exposure of Trp-512 in different nucleotide states, we performed acrylamide quenching experiments on W512-MDE in the presence of MgADP-BeF X , MgADP-AlF 4 Ϫ , MgATP, MgADP, and in the absence of nucleotide (rigor) (Fig. 3 and Table II ). The Stern-Volmer relationship was used to quantitatively determine the amount of acrylamide quenching (see "Experimental Procedures"). (Table II) . These data suggest that Trp-512 remains in a solvent exposed conformation upon MgATP binding, becomes more protected from solvent during the process of and following ATP hydrolysis, adopts a more solvent exposed conformation following P i release, and remains in a similar environment upon ADP release.
Energy Transfer from Trp-512 to mant-labeled Nucleotides/ Analogs-We examined the amount of FRET from Trp-512 to mant-labeled nucleotides and nucleotide analogs (MgATP, MgADP, MgADP-BeF X , MgADP-AlF 4 Ϫ ), to monitor changes in the distance between Trp-512 and the active site of myosin in different nucleotide states. Binding of mantATP or mantADP to W512-MDE was examined by titrating 0.6 M W512-MDE with mant-labeled nucleotides (0.5-5.0 M) and monitoring the enhanced fluorescence of mantATP or mantADP known to occur upon myosin binding. This analysis demonstrated that there was a 2-fold increase in mant fluorescence upon binding myosin, similar to previous results (12) , and allowed us to determine the concentration of mantADP (1.5 M) or mantATP (1.8 M) at which W512-MDE was fully saturated with nucleotide (data not shown). The excitation spectra of mant-labeled nucleotides/analogs (3.0 M) in the presence of W512-MDE (0.6 M) shown in Fig. 4 was corrected by subtracting the fluorescence from the unbound mant-labeled nucleotides assuming W512-MDE was 100% saturated with nucleotide. The efficiency of energy transfer, quantified by monitoring the change Table II . in the acceptor excitation spectrum at 285 nm, the peak excitation wavelength of Trp-512 (see "Experimental Procedures"), is highest when W512-MDE is complexed with mantADP-BeF X (43.5 Ϯ 3.3%), somewhat lower when complexed with mant-ADP-AlF 4 Ϫ (30.3 Ϯ 6.7%) or mantATP (35.4 Ϯ 5.5%), and much lower in the presence of mantADP (13.0 Ϯ 1.3%) (Table III) (Table III) . Thus, Trp-512 is the closest to the active site in the MgATP state, moves ϳ1-3 Å away in the MgADP⅐P i state, and upon P i release from the active site and formation of the strongly bound state Trp-512 moves an additional ϳ5-7 Å away from the active site.
DISCUSSION
Determining how myosin converts chemical energy via ATP hydrolysis into mechanical work and force generation is critical for understanding how motor proteins such as myosin function. The intrinsic fluorescence of myosin is sensitive to nucleotide binding and MgATP hydrolysis (7) (8) (9) (10) (11) (12) (13) , although the structural changes that lead to these alterations in intrinsic fluorescence have not been clearly elucidated. We have developed an extremely sensitive method utilizing mutants of smooth muscle myosin containing only one of the three conserved tryptophans among smooth muscle, skeletal muscle, and Dicty myosin II (Trp-441, Trp-512, and Trp-597) to examine which of these residues is responsible for the observed changes in intrinsic fluorescence observed in all three myosin isoforms. In the current study, only Trp-512 appears to be sensitive to nucleotide binding and hydrolysis. Because Trp-512 is located on the rigid relay loop connecting the converter and actin-binding regions to the active site of myosin, we have exploited the fluorescence changes observed in Trp-512 to determine the direction of movement and alterations in environment of the rigid relay loop during the MgATPase cycle of smooth muscle myosin. Therefore, we have identified key structural rearrangements in the rigid relay loop that allow coupling from the active site to the actin-binding and converter/lever arm regions of myosin.
Functional Properties of W441-, W512-, and W597-MDEEnzymatic assays were used to determine the extent to which the conservative mutations made in the W441-, W512-, and W597-MDE constructs affected the native properties of myosin by comparing them to WT-MDE. The actin-activated ATPase properties of W441-, W512-, and W597-MDE demonstrated a 4 -5-fold reduction in the maximal ATPase rate, whereas their K m values were comparable with those of WT-MDE (Table I ). Despite the relatively modest effect on enzymatic function, we suggest that these mutants are extremely valuable in examining the structural basis of the MgATPase cycle of myosin, because their ability to hydrolyze ATP in an actin-dependent manner was maintained.
Tryptophan Fluorescence Enhancement in Myosin-We observed no changes in the fluorescence of W441-and W597-MDE in the presence of MgATP or MgADP. However, the W512-MDE fluorescence was enhanced ϳ31% in the presence of MgADP-BeF X (i.e. the M⅐ATP state) and MgADP-AlF 4 Ϫ (i.e. the transition state between the M⅐ATP and M⅐ADP⅐P i states), increased ϳ5% further in the presence of MgATP (i.e. predominantly the M⅐ADP⅐P i state), and was reduced ϳ6% upon P i release (i.e. the M⅐ADP state). We obtained similar results, although lower in magnitude, for the relative changes in the intrinsic tryptophan fluorescence of WT-MDE. Thus, Trp-512 appears to be the only nucleotide-sensitive tryptophan in MDE and, because of the high degree of sequence conservation at this site across myosin isoforms, is probably solely responsible for the fluorescence enhancements observed in skeletal muscle and Dicty myosin as well. These results are consistent with other studies, suggesting that this conserved tryptophan residue is responsible for at least some of the ATP-sensitive intrinsic fluorescence signal of myosin (24 -26) . Batra and Manstein (41) have demonstrated that when Trp-501, the equivalent residue in Dicty myosin, is substituted with tyrosine (W501Y), no fluorescence enhancement was observed in the presence of MgATP. Hence, the other tryptophans in the W501Y construct did not appear to contribute to the ATP sensitivity of Dicty myosin. However, Dicty myosin only displays enhanced fluorescence upon the hydrolysis of ATP (42), whereas smooth and skeletal muscle myosins demonstrate an increase upon ATP binding and a further increase upon the hydrolysis of ATP (see the ATPase scheme in the Introduction). Thus, the fluorescence enhancement demonstrated in both smooth and skeletal muscle myosin upon ATP binding may result from structural changes in Trp-512, but these changes may be unique to vertebrate muscle myosin. Our results suggest the structural changes that occur in the rigid relay loop and lead to the fluorescence changes in Trp-512 during the hydrolysis step may be conserved among all three myosin isoforms. It is also possible that other nonconserved tryptophans in MDE are sensitive to nucleotide binding and hydrolysis, especially in the ATP-bound state (i.e. MgADP-BeF X ) because the fluorescence mADP, mATP, etc.) . The excitation spectrum of mant-ADP (3.0 M) free in solution is compared with mant-labeled nucleotides/analogs bound to W512-MDE (0.6 M). The peak fluorescence excitation at 285 nm, which is the peak excitation wavelength of Trp-512, was used to quantify the energy transfer efficiency in different nucleotide states (see Equations 1-4). The energy transfer efficiencies and the corresponding distances between the donor/acceptor pairs in each nucleotide state are summarized in Table III . enhancement of W512-MDE is 3.5-fold higher than WT-MDE, instead of 2.3-2.5-fold in the other nucleotide states. One other tryptophan that could be nucleotide-sensitive in WT-MDE is Trp-29 because it is unique to smooth muscle myosin and conformational changes around this residue are quite possible given its location near the converter region. The fluorescence enhancement of W512-MDE was only 2-3-fold greater than WT-MDE, containing seven tryptophans and potential for a 7-fold stronger background fluorescence signal. One possible explanation for this result may be that the structure of W512-MDE is modified compared with WT-MDE, altering the normal nucleotide induced conformational changes sufficiently to decrease the fluorescence enhancement levels of W512-MDE. However, we feel this is unlikely because the fluorescence enhancement profile of W512-MDE follows a similar pattern to WT-MDE and other studies with smooth muscle myosin (8, 12) . Alternatively, other tryptophan residues in WT-MDE may contain extremely low quantum yields and be essentially nonfluorescent. We previously measured the quantum yields of two other endogenous tryptophans, Trp-546 and Trp-625, in MDE (27) , which were similar to the three conserved tryptophans examined in this study. This suggests that the two endogenous tryptophans not yet analyzed, Trp-29 and Trp-36, may be highly quenched in the WT-MDE construct.
Conformational Changes in Trp-512-To gain a better understanding of the changes in the environment of Trp-512 in different nucleotide states, we performed acrylamide quenching experiments with W512-MDE bound to MgADP-BeF X , MgADP-AlF 4 Ϫ , MgATP, MgADP, or in the absence of nucleotide (rigor). Our results demonstrate that Trp-512 remains in a solvent exposed conformation in the MgATP-bound state (i.e. MgADP-BeF X ), becomes more protected from solvent in the transition (i.e. MgADP-AlF 4 Ϫ ) and MgADP⅐P i states (i.e. MgATP), and returns to a more exposed conformation following P i release (i.e. MgADP). Because we were not able to accurately determine the fluorescence lifetime of Trp-512 under all conditions studied, we did not determine bimolecular quenching constants from our acrylamide quenching data. However, we still believe that the calculated dynamic quenching constants are likely to be reflective of the overall accessibility of Trp-512 in our experiments. The quantum yields determined in the absence or presence of various nucleotides and analogs, which reflect the same excited state relaxation properties as the corresponding fluorescence lifetime values, differed by no more than 50%, and scaling the calculated dynamic quenching constants by the relative quantum yield values did not qualitatively change the interpretation of our data.
Quenching experiments performed on the corresponding residue in skeletal muscle myosin, Trp-510, demonstrated a decrease in the dynamic quenching constant and thus the solvent exposure of Trp-510 upon MgATP binding and a further decrease following the hydrolysis of ATP (26) . Our dynamic quenching constants (K SV ) follow a similar trend, suggesting that conformational changes in the rigid relay loop may be quite similar in smooth and skeletal muscle myosin. Park et al. (26) suggested that the cleft surrounding Trp-510, referred to as the "probe binding cleft," closes as myosin binds and hydrolyzes ATP. Hence, closure of the probe binding cleft as ATP is hydrolyzed would correspond to the pre-powerstroke state, and opening of this cleft during P i release might be part of the structural changes in myosin responsible for the transition to the strongly bound state and the powerstroke. Interestingly, studies that have examined conformational changes in the lever arm have revealed a relationship between the nucleotide state and the position of the lever arm (21, 22) . Thus, the rigid relay loop may communicate structural changes from the active site to the converter and lever arm regions of myosin.
Movement of the Rigid Relay Loop-We specifically examined movement of the rigid relay loop in relation to the active site of myosin by performing FRET experiments between Trp-512 and mant-labeled nucleotides. The distances calculated between Trp-512 and mant-labeled nucleotides, which ranged from 26 to 34 Å, were similar to the distances between Trp-512 and the nucleotide bound to the active site of myosin in various crystal structures (5, 6, 43) . We assumed that the orientation factor (K 2 ) was 2 ⁄3 (i.e. the rotational motion of our donor and acceptor probes was unrestricted during the fluorescence lifetime of the donor) and that K 2 as well as the extinction coefficients of the donor and acceptor were unchanged in the different nucleotide states, which may have introduced error into our distance and efficiency calculations. However, because our calculated distances were similar to those observed in the available crystal structures, our assumptions probably are valid or at least do not alter our qualitative interpretation of the data. Previous studies that have examined the conformation of mant-ADP, mantATP, and mantADP-BeF X suggest that the mant fluorophore has a similar conformation in each stage of the skeletal muscle myosin MgATPase cycle (44) . Thus, the reproducible changes in the excitation spectrum of mant-labeled nucleotides/analogs bound to W512-MDE most likely represent significant changes in the relative distance between Trp-512 and mant-labeled nucleotides caused by movement of Trp-512, which can be discussed in terms of the structure of myosin.
The distance between Trp-512 and mant-labeled nucleotides was closest in the weak binding states (MgATP and MgADP⅐P i ) and furthest away in the strong binding state (MgADP). Studies that have examined the position of the lever arm of skeletal muscle and Dicty myosin during the MgATPase cycle suggest that it is closest to the active site in the MgADP⅐P i state, FIG. 5 . Structural model to explain the proposed conformational changes in myosin during its MgATPase cycle. Binding of MgATP to myosin (M*⅐MgATP) may result in closure of the actinbinding cleft and dissociation of the strongly bound rigor complex, whereas the position of the lever arm is not stabilized by the converter domain (Trp-512 is exposed and close to the active site). The hydrolysis of MgATP (M**⅐MgADP⅐P i ) locks the lever arm into the pre-powerstroke position because of more contacts between the rigid relay loop and the converter region, whereas the actin-binding cleft remains closed (Trp-512 is buried and close to the active site). Upon P i release (M*⅐MgADP), the conformation of the converter domain and lever arm undergo a large rotation, producing the powerstroke of muscle contraction. Also, P i release may open the actin-binding cleft resulting in a large increase in the affinity of myosin for actin (Trp-512 is exposed and far away from the active site). The release of ADP from the active site (rigor) changes the converter/lever arm slightly, which may be associated with the additional movement of the lever arm (Trp-512 becomes slightly more buried, but similar to M*⅐MgADP).
farthest away in the MgADP and rigor states, and intermediate in the MgATP state (21, 22) . Thus, the position of the lever arm may change as a result of the position of the converter region, which is dependent on contacts with the rigid relay loop containing Trp-512 to communicate changes from the active site. Contacts between the rigid relay loop and the converter region, which have been discussed in detail in previous structural studies (5, 6) , suggest the highly conserved loop moves as a rigid body during the MgATPase cycle. The coupling pathway proposed by Dominguez et al. (5) suggests that the highly conserved switch II region changes conformation, propagating structural changes from the active site to the rigid relay loop and then to the converter and lever arm regions. Our results suggest that in solution, when MgATP binds, the rigid relay moves closer to the active site while remaining exposed to solvent, perhaps because of lack of contacts with the converter region. In the MgADP⅐P i state, the rigid relay loop may form more contacts with the converter region, causing Trp-512 to be more protected from solvent while remaining close the active site. However, upon P i release and formation of the strong binding state, contacts of the rigid relay loop with the converter may be disrupted because of the conformational changes propagated from the switch II region. This disruption may result in the rigid relay loop and Trp-512 becoming more solvent exposed and moving further away from the active site. The end result is that the lever arm is free to rotate around the converter region during the transition from the weakly to strongly bound acto-myosin complexes.
Model of Coupling Pathways during the MgATPase Cycle of Myosin-We propose a simple model, depicted in Fig. 5 , to explain how changes at the active site of myosin may be coupled to changes in the actin-binding region and the position of the lever arm. First, starting in the rigor state, when MgATP binds the switch II region changes conformation, leading to closure of the actin-binding cleft and disruption of contacts with actin. The rigid relay loop moves closer to the active site, whereas contacts between the rigid relay loop and the converter domain are minimal, resulting in Trp-512 remaining solvent exposed and the lever arm being free to adopt multiple conformations. After ATP hydrolysis, the rigid relay loop moves further away from the active site, whereas Trp-512 adopts a more protected conformation, because of greater contacts of the rigid relay loop with the converter and stabilization of the lever arm in the pre-powerstroke conformation. During P i release, Trp-512 adopts a more solvent exposed conformation because of movement of the rigid relay loop away from active site when the switch II region is no longer stabilized by the ␥-phosphate of ATP within the active site. As a result, the rigid relay loop contacts with the converter domain are disrupted, and the lever arm can proceed through its powerstroke. Also, the actin-binding cleft may shift to the open position during P i release allowing strong actin binding to occur. Finally, ADP release may only cause a small local conformational change in the rigid relay loop and Trp-512, whereas the lever arm rotates further during formation of the rigor complex (18) . Although we have suggested above that the actin-binding cleft is closed in the weak binding states (M⅐ATP and M⅐ADP⅐P i ) and open in the strong binding states (M and M⅐ADP) (5), the conformation of the actin-binding cleft in the presence of actin is still controversial, and the exact opposite model has been proposed (45) .
Conclusions-In summary, we have demonstrated that Trp-512 may be the sole conserved tryptophan responsible for the changes in intrinsic tryptophan fluorescence during the MgATPase cycle of the class II myosin isoforms. Furthermore, we provide direct evidence for structural changes that occur in the rigid relay loop containing Trp-512 in different stages of MgATPase cycle. Thus, the observed alterations in the rigid relay loop are likely to be involved in coupling conformational changes from the active site to the actin-binding and converter/ lever arm regions of myosin during muscle contraction.
